Sort
16,300 grants matching “fatty liver disease”
Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies
$653,400Joshua Wiley Knowles · Stanford University · R01 · FY2019 · DK
Managing Atherosclerosis by Modulating HDL Function
$653,301M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2015 · HL
Mitochondrial DAMPs-driven Mechanisms of Liver Fibrosis in NASH
$653,226Yury Popov · Beth Israel Deaconess Medical Center · R01 · FY2024 · DK
Shape up! Kids
$653,196John Alan Shepherd · University Of Hawaii At Manoa · R01 · FY2019 · DK
Regulation and Role of Phosphatidate Phosphatase in Lipid Metabolism
$653,120George M. Carman · Rutgers, The State Univ Of N.J. · R35 · FY2023 · GM
Regulation and Role of Phosphatidate Phosphatase in Lipid Metabolism
$653,120George M. Carman · Rutgers, The State Univ Of N.J. · R35 · FY2024 · GM
Regulation and Role of Phosphatidate Phosphatase in Lipid Metabolism
$653,120George M. Carman · Rutgers, The State Univ Of N.J. · R35 · FY2022 · GM
Clock modulation in circadian desynchrony induced diabetes and atherovascular disease - mechanisms and interventions
$653,102Vijay K Yechoor · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK
Regulation and Role of Phosphatidate Phosphatase in Lipid Metabolism
$652,774George M. Carman · Rutgers, The State Univ Of N.J. · R35 · FY2021 · GM
Bariatic Surgery: Outcomes & Impact on Pathophysiology
$652,763Paul David Berk · Columbia University Health Sciences · U01 · FY2007 · DK
PGC1alpha Pathway: Novel Intracellular and Extracellular Mediators
$652,543Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2024 · DK
Non Alcoholic Steatohepatitis Clinical Research Network
$652,507Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2020 · DK
Vitamin E Pharmacokinetics And Biomarkers In Normal And Obese Women
$652,454Mark A Levine · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Vitamin C (ascorbic acid) recommended dietary ingestion
$652,454Mark A Levine · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
A Dietary Intervention to Improve Glucose Tolerance in Adults with Cystic Fibrosis
$652,302Jessica Alejandra Alvarez · Emory University · R01 · FY2023 · DK
Hepatotoxic effects of perfluoroalkyl substances: a new epidemiological approach for studying environmental fatty liver disease
$652,194Vaia Lida Chatzi · University Of Southern California · R01 · FY2022 · ES
Novel Biguanides to Treat Type 2 Diabetes
$651,885Ken W Batchelor · Novatarg, Inc. · R44 · FY2015 · DK
Molecular MR Imaging of Hepatic Fibrogenesis
$651,816Peter D Caravan · Massachusetts General Hospital · R01 · FY2019 · DK
Molecular MR Imaging of Hepatic Fibrogenesis
$651,816Peter D Caravan · Massachusetts General Hospital · R01 · FY2020 · DK
Novel roles of PDK4 in regulating mitochondrial protein phosphorylation, carbon flux and metabolic resilience
$651,498Deborah M Muoio · Duke University · R01 · FY2023 · DK
Prenatal stress and diet, and the fetal epigenome
$651,498Cathrine Hoyo · North Carolina State University Raleigh · R01 · FY2022 · MD
Weight-Loss Diet Intervention on Cardiometabolic Factors of Gut Microbiota
$651,456Lu Qi · Tulane University Of Louisiana · R01 · FY2020 · DK
Targeting bile acid composition to treat metabolic diseases
$651,439Wendong Huang · Beckman Research Institute/City Of Hope · R01 · FY2024 · DK
Mechanisms of Insulin Resistance in Man
$651,329Rita Basu · Mayo Clinic Rochester · R01 · FY2010 · DK
Confounder-Corrected Quantitative MRI Biomarkers of Hepatic
$651,213Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2016 · DK